{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:45:43Z","timestamp":1773697543496,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1099452"],"award-info":[{"award-number":["APP1099452"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1117065"],"award-info":[{"award-number":["APP1117065"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1142757"],"award-info":[{"award-number":["APP1142757"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.athoracsur.2022.02.047","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T02:03:36Z","timestamp":1647050616000},"page":"1434-1440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perioperative Cefazolin Prophylaxis in Pediatric Cardiac Surgery: A Prospective, Cohort Study"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-5532","authenticated-orcid":false,"given":"Jessica","family":"Suna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supreet P.","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Bierbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus P.J.","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavey","family":"Dorofaeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Alphonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2022.02.047_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00801907","article-title":"Incidence of congenital heart disease. I. Postnatal incidence","volume":"16","author":"Hoffman","year":"1995","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib2","first-page":"34","article-title":"Nosocomial infections in pediatric patients following cardiac surgery","volume":"69","author":"Guardia Cami","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1010-7940(01)00991-5","article-title":"Superficial and deep sternal wound complications: incidence, risk factors and mortality","volume":"20","author":"Ridderstolpe","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/ijccm.IJCCM_62_17","article-title":"Hospital-acquired infection: prevalence and outcome in infants undergoing open heart surgery in the present era","volume":"21","author":"Sahu","year":"2017","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-5223(19)42646-9","article-title":"A\u00a0study of antibiotic prophylaxis in cardiac surgery","volume":"57","author":"Fekety","year":"1969","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0022-5223(19)34723-3","article-title":"Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials","volume":"104","author":"Kreter","year":"1992","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S1047951107000066","article-title":"Perioperative antibiotic prophylaxis in paediatric cardiac surgery","volume":"17","author":"Alphonso","year":"2007","journal-title":"Cardiol Young"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/sur.2018.272","article-title":"Antibiotic prophylaxis in pediatric cardiac surgery: where are we and where do we go? A systematic review","volume":"20","author":"Jaworski","year":"2019","journal-title":"Surg Infect"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2016.12.014","article-title":"Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured review","volume":"49","author":"Paruk","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0003-4975(10)61646-3","article-title":"Serum cefazolin levels during cardiopulmonary bypass","volume":"29","author":"Akl","year":"1980","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jtcvs.2005.11.047","article-title":"Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest","volume":"131","author":"Caffarelli","year":"2006","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dkx439","article-title":"Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass","volume":"73","author":"Calic","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0003-4975(02)03916-4","article-title":"Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery","volume":"74","author":"Fellinger","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/sur.2014.250","article-title":"Validation of a dosing strategy for cefazolin for surgery requiring cardiopulmonary bypass","volume":"16","author":"Hollis","year":"2015","journal-title":"Surg Infect"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jtcvs.2016.04.024","article-title":"Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery","volume":"152","author":"Lanckohr","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib17","first-page":"29","article-title":"Cefazolin concentrations in serum during cardiopulmonary bypass surgery","volume":"31","author":"Miglioli","year":"2005","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11748-015-0552-9","article-title":"A\u00a0novel protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery under cardiopulmonary bypass","volume":"63","author":"Odaka","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib19","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.jvca.2015.03.026","article-title":"Continuous intraoperative cefazolin infusion may reduce surgical site infections during cardiac surgical procedures: a propensity-matched analysis","volume":"29","author":"Trent Magruder","year":"2015","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01360-18","article-title":"Antimicrobial prophylaxis for patients undergoing cardiac surgery: intraoperative cefazolin concentrations and sternal wound infections","volume":"62","author":"Zelenitsky","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/phar.1689","article-title":"Impact of intraoperative continuous-infusion versus intermittent dosing of cefazolin therapy on the incidence of surgical site infections after coronary artery bypass grafting","volume":"36","author":"Shoulders","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib22","first-page":"605","article-title":"Antibiotic prophylaxis in cardiac surgery.","volume":"38","author":"Kriaras","year":"1997","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib23","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.athoracsur.2006.09.046","article-title":"The society of thoracic surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice","volume":"83","author":"Engelman","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib24","series-title":"IBM SPSS statistics for windows","year":"2019"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jcan.2003.51","article-title":"Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms","volume":"17","author":"Haessler","year":"2003","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jac\/dkt527","article-title":"Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates","volume":"69","author":"De Cock","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/CCM.0000000000002817","article-title":"Beta-lactam therapeutic drug management in the PICU","volume":"46","author":"Cies","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/bja\/aex026","article-title":"Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial","volume":"118","author":"Naik","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/jac\/dky574","article-title":"Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children","volume":"74","author":"Cies","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/aca.ACA_106_19","article-title":"Plasma concentrations of cefazolin in pediatric patients undergoing cardiac surgery","volume":"24","author":"Lapmahapaisan","year":"2021","journal-title":"Ann Cardiac Anaesth"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezab251","article-title":"Cefazolin prophylaxis in children undergoing cardiac surgery with the use of cardiopulmonary bypass\u2014is the dosing correct?","author":"Jaworski","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2022.02.047_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ajhp\/zxz344","article-title":"Surgical site infection rate is higher following hip and knee arthroplasty when cefazolin is underdosed","volume":"77","author":"Morris","year":"2020","journal-title":"Am J Health Syst Pharm"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497522003320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497522003320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:37:29Z","timestamp":1762087049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497522003320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0003497522003320"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2022.02.047","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Cefazolin Prophylaxis in Pediatric Cardiac Surgery: A Prospective, Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2022.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The Society of Thoracic Surgeons","name":"copyright","label":"Copyright"}]}}